Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
NASDAQ:BPTH
Bio-Path Holdings (BPTH) Stock Price & Analysis
359 Followers
BPTH Stock Chart & Stats
Day’s Range$2.35 - $2.75
52-Week Range― - ―
Previous Close$2.49
Volume160.31K
Average Volume (3M)N/A
Market Cap
$4.20M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 16, 2024EPS Estimate
-$4.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$40.00Price Target Upside1418.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bio-Path Holdings News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BPTH FAQ
What was Bio-Path Holdings’s price range in the past 12 months?
Currently, no data Available
What is Bio-Path Holdings’s market cap?
Currently, no data Available
When is Bio-Path Holdings’s upcoming earnings report date?
Bio-Path Holdings’s upcoming earnings report date is May 16, 2024 which is in 20 days.
How were Bio-Path Holdings’s earnings last quarter?
Bio-Path Holdings released its earnings results on Mar 08, 2024. The company reported -$3.43 earnings per share for the quarter, beating the consensus estimate of -$5.4 by $1.97.
Is Bio-Path Holdings overvalued?
According to Wall Street analysts Bio-Path Holdings’s price is currently Undervalued.
Does Bio-Path Holdings pay dividends?
Bio-Path Holdings does not currently pay dividends.
What is Bio-Path Holdings’s EPS estimate?
Bio-Path Holdings’s EPS estimate is -$4.54.
How many shares outstanding does Bio-Path Holdings have?
Currently, no data Available
What happened to Bio-Path Holdings’s price movement after its last earnings report?
Bio-Path Holdings reported an EPS of -$3.43 in its last earnings report, beating expectations of -$5.4. Following the earnings report the stock price went down -6.421%.
Which hedge fund is a major shareholder of Bio-Path Holdings?
Currently, no hedge funds are holding shares in BPTH
---
Bio-Path Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$40.00 (1418.03% Upside)
$40.00 (1418.03% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.9%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.97%
12-Months-Change
Fundamentals
Return on Equity
-220.02%
Trailing 12-Months
Asset Growth
-79.84%
Trailing 12-Months
Company Description
Bio-Path Holdings
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
---
BPTH Earnings Call
Q4 2024
0:00 / 0:00
---
BPTH Stock 12 Months Forecast
Average Price Target
$40.00
▲(1418.03% Upside)
Technical Analysis
Best Analysts Covering BPTH
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-50.92%
reiterated a buy rating 8 days ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -50.92% per trade.
---